Arthroscopic Partial Trapezictomy With Hematoma Distraction in Basal Thumb Arthritis
Arthroscopic Partial Trapeziectomy With Hematoma Distraction in Basal Thumb Arthritis
1 other identifier
interventional
24
1 country
1
Brief Summary
The basal joint, also referred to as the carpometacarpal (CMC) joint, of the thumb is one of the joints most commonly affected by arthritis. CMC joint arthritis can lead to decreased grip and pinch strength and impairment of activities of daily living
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2023
CompletedFirst Posted
Study publicly available on registry
February 27, 2023
CompletedStudy Start
First participant enrolled
December 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2024
CompletedJanuary 17, 2024
January 1, 2024
9 months
February 17, 2023
January 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
DASH score
score for pinch grip
1 year
Study Arms (1)
Arthroscopic partial Trapezictomy With Hematoma Distraction
EXPERIMENTALInterventions
Arthroscopic Partial Trapeziectomy with Hematoma Distraction in Basal Thumb Arthritis
Eligibility Criteria
You may qualify if:
- Age: adult patient \> 20years.
- Gender: Males \& Females.
- Symptomtic patient.
- Failed conservative treatment of 6 months duration
- Eaton stage II, III and IV of base thumb arthritis
You may not qualify if:
- Patient presenting with flexor carpi radialis rupture
- Previous Zancolli arthroplasty
- Associated comorbidity as: RA,DM with joint destruction
- Infection
- Poor Skin Condition
- Active Pateint With High Joint Demand
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alazhar
Asyut, Egypt
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
February 17, 2023
First Posted
February 27, 2023
Study Start
December 30, 2023
Primary Completion
October 1, 2024
Study Completion
December 5, 2024
Last Updated
January 17, 2024
Record last verified: 2024-01